BeStock  

Repligen RGEN

US equityMarket cap rank #1375Medical Instruments & Supplies
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RGEN at a glance

Repligen stock (RGEN) sits at $163.81, down 3.81% today. The business is worth $10.47B in the market, good for #1375 of 3753 on our coverage list.

The 52-week range is $100.99 to $198.87. Today's price is about 64% of the way from the low to the high. Holders are ahead 0.8% over twelve months, but down 9.8% across the last three months.

Price is below the 50-day average ($177.16) but above the 200-day ($145.74); RSI is 43, and the last 30 sessions moved at roughly 49% annualized volatility.

In the quarter ended Sep 2026 the company brought in $209.31M of revenue, up 10.9% from a year earlier, and a net loss of $38.43M.

8 analysts follow the stock and the average call is "buy". The mean target, $210.29, sits 28.4% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$163.81 / $193.34
Average price today$165.31
Volume697.7KAvg (90d) 1.20M
Turnover$115.34M
Turnover rate1.14%of shares outstanding
Volume ratio0.86vs. recent average pace
Day amplitude4.20%
Market cap$10.47B
Float market cap$9.99B
Shares outstanding60.96M
EPS (TTM)$0.86
P/B5.01
Book value / share$32.72
Net profit (TTM)$54.97M
Net assets$2.09B
30-day volatility48.8%annualized
Avg daily range (ATR)4.93%of price, 14 days
Max drawdown (1y)-40.3%-15.8% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 24.9 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation0.6
Growth25.1
Profitability39.6
Momentum67.3
Financial health82.0
Analyst view61.9

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$210.29+28.4% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$171.55Close to fair value

Wall Street’s average 12-month target is $210.29, 28.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $171.55, so shares trade 4.5% below that estimate. On earnings multiple, it sits in the 12th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.8%
1 week
-2.4%
1 month
-8.3%
3 months
-9.8%
6 months
+42.4%
Year to date
0.0%
1 year
+0.8%
Day range
$162.47$169.61
52-week range
$100.99$198.87

Technical signals

Full technicals →
Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-5.6%Bearish
Price vs 50-day average-7.5%Bearish
Price vs 200-day average+12.4%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)42.7Bearish
MACD (12,26,9)-3.02Bearish
Bollinger band position16%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RGEN ranks on BeStock

Market value#1373 of 3734
Closeness to 52-week high#1282 of 3724
Dollar volume today#926 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RGEN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RGEN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RGEN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RGEN stock: common questions

Where is RGEN trading right now?

$163.81 is the latest print for RGEN, a move of -3.81% against yesterday's close of $170.29. Today's low and high so far: $162.47 and $169.61.

How large is Repligen by market value?

Equity value comes to $10.47B at the current price. By that measure it is number 1375 of the 3753 names in our coverage.

Is RGEN near its 52-week high or low?

The year's floor is $100.99 and the ceiling $198.87. Shares are 17.6% away from that ceiling.

Does Repligen pay a dividend?

Our data shows no dividend paid by Repligen over the trailing twelve months.

Is RGEN rated a buy by Wall Street?

Of 8 analysts, 88% say buy, 13% hold and 0% sell. Price targets average $210.29, with the most cautious at $180.00 and the most optimistic at $235.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RGEN.

Sign in to join the discussion.

Scroll to Top